Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Oncology
Search Medical Condition
Polyps Clinical Trials
A listing of Polyps medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (791) clinical trials
Do you have nasal polyps and struggle to control your symptoms despite treatment?
The Clinical Research Center is conducting a research study to evaluate the safety and effectiveness of Omalizumab (Xolair) compared with placebo for the treatment of chronic nasal polyps. The study consists of 10-14 visits over approximately 52 weeks. The medication is delivered by injection. To Qualify: You must be between ...
Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors
The key purpose of the main part of the study is to assess efficacy and safety of anetumab ravtansine as monotherapy or combination therapy for mesothelin expressing advanced solid tumors. The main purpose of the safety lead-in (dose-finding) part of the study is to determine the safety and tolerability of ...
Nasal Polyp Clinical Research
Dr. Craig LaForce, Dr. Karen Dunn and Dr. Magda Pugh are recruiting individuals with nasal polyps to participate in a research study involving an investigational medication
Severe Nasal Polyps
Effect of Mepolizumab (currently an approved medication for patients with asthma), or placebo for patients with severe nasal polyps This research study may be an option for you. Please see the eligibility criteria to see if you may qualify. Please reach out to our research staff if you have any ...
First-in-human Study of ATR Inhibitor BAY1895344 in Patients With Advanced Solid Tumors and Lymphomas
The ATR(ataxia-telangiectasia and Rad3 related protein) inhibitor BAY1895344 is developed for the treatment of patients with advanced solid tumors and lymphomas. The purpose of the proposed trial is to evaluate the safety and tolerability of BAY1895344, and to identify the maximum tolerated dose of BAY1895344 that could be safely given ...
Phase I Study of BAY1436032 in Isocitrate Dehydrogenase-1 (IDH1)-Mutant Advanced Solid Tumors
In patients with IDH1-R132X-mutant solid tumors treated with BAY1436032: 1. Determine the safety, tolerability, maximum tolerated dose (MTD) or recommended phase II dose (RP2D) of BAY1436032; 2. Evaluate the pharmacokinetic (PK) properties and pharmacodynamic (PD) effects of BAY1436032; 3. Look for preliminary evidence of clinical efficacy in patients treated with ...
Phase I Study of Anetumab Ravtansine in Hepatic or Renal Impairment
To characterize the safety, tolerability, pharmacokinetics and immunogenicity of anetumab ravtansine in subjects with advanced solid cancers and with different degrees of hepatic or renal impairment
Phase I Dose Escalation Study for BAY 1251152 in Patients With Advanced Cancer
Determine the safety, tolerability, pharmacokinetics, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of BAY 1251152 in patients with solid tumors and aggressive non-hodgkin's lymphoma (NHL).
Dose-escalation Study of BAY1129980
The relatively restricted C4.4a expression pattern provides a target for the selective delivery of a cytotoxic drug to C4.4.a-expressing tumor cells by means of a suitable antibody-drug conjugate. The subject population eligible for the current study will be those subjects with advanced malignancies known to express C4.4a, which are refractory ...
Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor
- This is the first study where BAY1163877 is given to humans. Impact of the study is to evaluate if patients with advanced solid cancers show advanced clinical benefit under the treatment with the pan FGFR inhibitor. Patients (all comers) will receive the study drug treatment in a dose-escalation scheme ...
